Jianfan Bio (300529.SZ) released its semi-annual performance report, with a net profit attributable to shareholders of 382 million yuan, a year-on-year decrease of 1.99%.

According to Zhitong Finance APP, Jianfan Biological (300529.SZ) released its semi-annual report for 2026. In the first half of 2026, the company achieved an operating revenue of 1.032 billion yuan, a year-on-year decrease of 8.99%; it achieved a net profit attributable to shareholders of the listed company of 382 million yuan, a year-on-year decrease of 1.99%; it achieved a net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, of 355 million yuan, a year-on-year decrease of 4.71%; basic earnings per share were 0.49 yuan.